Business context and reporting period
This is Welsbach Technology Metals Acquisition Corp.’s unaudited Form 10-Q for the quarter and nine months ended September 30, 2023, filed November 20, 2023. The request metadata names Evolution Metals & Technologies Corp., but that company is not identified as the registrant in the supplied filing. Welsbach is a shell company seeking a business combination; it had no operating business or operating revenue during the period. In September, it announced a non-binding letter of intent with a target in the critical materials space. The filing gives no assurance that a definitive agreement or transaction will result.
Financial highlights
| Metric | Period / date | Amount |
|---|---|---|
| Operating revenue | Three and nine months ended September 30, 2023 | None |
| Net income (loss) | Three months ended September 30, 2023 | $164,293 |
| Net income (loss) | Nine months ended September 30, 2023 | $(39,380) |
| Trust investment interest income | Nine months ended September 30, 2023 | $1,855,102 |
| Operating expenses | Nine months ended September 30, 2023 | $1,744,482 |
| Cash used in operating activities | Nine months ended September 30, 2023 | $700,236 |
| Cash and restricted cash | September 30, 2023 | $307,761 total: $94,579 cash and $213,182 restricted |
| Trust investments | September 30, 2023 | $39,613,658 |
| Working capital deficit | September 30, 2023 | $6,807,020 |
| Related-party notes and working capital loans | September 30, 2023 | $2,780,471 |
| Deferred underwriting fee payable | September 30, 2023 | $2,704,690; payable only upon a completed business combination |
Gross profit, operating margins and conventional debt or liquidity ratios are not meaningful for this pre-combination shell; the filing does not provide a clear value for those measures.
Changes versus the prior comparable period
- Third-quarter net income of $164,293 compared with a net loss of $816,133 in Q3 2022, chiefly reflecting higher trust interest income ($507,906 versus $349,006), lower general and administrative expense ($555,524 versus $1,062,557), and a $261,911 income tax benefit.
- The nine-month net loss narrowed to $39,380 from $1,594,068 in 2022, as trust interest income rose to $1,855,102 from $461,130 and operating expenses declined to $1,744,482 from $1,852,616.
- Trust assets fell from $79.6 million at December 31, 2022 to $39.6 million at September 30, 2023, mainly due to shareholder redemptions. Stockholders redeemed about $42.6 million in March and $15.7 million in connection with the September extension; the latter payment was made October 12.
- Related-party notes and working capital loans increased from $1.55 million at year-end 2022 to $2.78 million at September 30, 2023. These notes generally bear no interest and may be repaid or converted upon a business combination, subject to their terms.
Outlook, risks and unusual items
- Stockholders extended the combination deadline to June 30, 2024 without a further trust contribution. Failure to complete a business combination by the deadline may require liquidation and redemption of public shares.
- Management reported substantial doubt about the company’s ability to continue as a going concern. The company has little cash outside the trust, a working capital deficit, no revenue, and may need additional sponsor or other financing; such funding is not assured.
- The company recorded a $583,520 excise tax payable related to 2023 share redemptions. It says the liability may be offset by qualifying share issuances in the same tax year and would not be due if the company liquidates before December 31, 2023.
- Nasdaq notified the company after quarter-end that it did not meet the minimum 400-holder listing requirement. Nasdaq granted an extension to April 8, 2024 for regaining compliance.
- On November 8, 2023, the company moved trust funds from U.S. Treasury obligations to an interest-bearing deposit account to mitigate investment-company-status risk.
- Risks include failure to identify or complete a suitable transaction, inability to obtain financing, redemptions reducing cash available, creditor claims against trust assets, conflicts of interest involving the sponsor and service providers, market volatility, inflation, interest rates and geopolitical events. The filing reports no legal proceedings and no off-balance-sheet arrangements.
Important facts for investors to verify
- Whether the critical-materials target LOI progressed to a definitive agreement, and the transaction’s terms, financing and closing conditions.
- Current trust balance and redemption obligations after the October 12 payment, and the cash available after taxes and other claims.
- Ability to fund operations and transaction expenses through June 30, 2024, including further sponsor loans and their repayment or conversion terms.
- Nasdaq holder-count compliance by April 8, 2024 and any effect on continued listing or trading liquidity.
- Final excise-tax treatment, including potential offsets and whether the recorded liability is ultimately payable.
- The filing’s extension and liquidity-date disclosures: some narrative refers to an earlier August 2023 date, while the September extension set June 30, 2024 as the combination deadline.